Skip to main content
GutCited

Clostridioides difficile Infections: Prevention and Treatment Strategies.

Elvira Ingrid Levy, Meltem Dinleyici, Ener Dinleyici, Yvan Vandenplas
Review Advances in experimental medicine and biology 2024 2 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D39060738'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Patients with C. difficile infection
Intervention
Clostridioides difficile Infections: Prevention and Treatment Strategies. None
Vergleichsgruppe
None
Primärer Endpunkt
C. difficile infection treatment outcomes
Wirkungsrichtung
Positive
Verzerrungsrisiko
Unclear

Abstract

Clostridioides difficile is the most common causative agent of antibiotic-associated diarrhea. This spore forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and in hospital settings, whose severity can vary widely from an asymptomatic infection to a lethal disease. While discontinuation of antimicrobial agents and antibiotic treatment of the infection remain the cornerstone of therapy, more recent fecal microbiota transplantation has also been valid as a therapy. The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy. Although there are studies in adults with microbiota-targeted new generation therapies and Clostridium difficile vaccines, there are no data in the paediatric age group yet.

Zusammenfassung

The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy and there are no data in the paediatric age group yet.

Used In Evidence Reviews

Similar Papers